We successfully obtained the peptide NSP1 that specifically binds to lung cancer NCI-H1299 cells by in vivo phage display, which provide a theoretical basis for NSCLC early diagnosis and targeted therapy. The gene discussed is SH2D3A; the disease is non-small cell lung carcinoma.